Abstract
UNLABELLED: Targeted delivery of antiosteoarthritic drug diacerein to articular tissue could be a major achievement and soluble polysaccharide chondroitin sulfate (ChS) may be a suitable agent for this. Therefore, diacerein loaded solid lipid nanoparticles modified with ChS (ChS-DC-SLN) were prepared for synergistic effect of these agents to combat multidimensional pathology of osteoarthritis (OA). Prepared formulation were of size range 396±2.7nm, showed extended release up to 16h and increased bioavailability of diacerein by 2.8 times. ChS-DC-SLN were evaluated for their effect on histopathology of femoro-tibial joint of rat knee and amount of ChS and rhein (an active metabolite of diacerein) at targeted site. Concentration of rhein was significantly higher in case of ChS-DC-SLN (7.8±1.23μg/ml) than that of drug dispersion (2.9±0.45μg/ml). It can be stated that ChS served as homing to articular cartilage for targeting of drug. Thus, ChS-DC-SLN have great potential to enhance the overall efficacy of treatment for OA.
FROM THE CLINICAL EDITOR: This study demonstrates the feasibility of targeted delivery of diacerein to articular tissue using soluble polysaccharide chondroitin sulfate as the targeting vector. This approach has the potential to significantly increase anti-arthritic drug concentration in joints without leading to systemic toxicity.
Original language | English |
---|---|
Pages (from-to) | 1031-40 |
Number of pages | 10 |
Journal | Nanomedicine: Nanotechnology, Biology and Medicine |
Volume | 10 |
Issue number | 5 |
DOIs | |
Publication status | Published - 7 Feb 2014 |
Keywords
- Animals
- Anthraquinones/administration & dosage
- Anti-Inflammatory Agents, Non-Steroidal/administration & dosage
- Cartilage, Articular/drug effects
- Chondroitin Sulfates/chemistry
- Drug Carriers/chemistry
- Female
- Lipids/chemistry
- Male
- Nanoparticles/chemistry
- Osteoarthritis/drug therapy
- Rats